MA39189A1 - Dérivés de 1h-indazole et de 1h-indole antibactériens - Google Patents

Dérivés de 1h-indazole et de 1h-indole antibactériens

Info

Publication number
MA39189A1
MA39189A1 MA39189A MA39189A MA39189A1 MA 39189 A1 MA39189 A1 MA 39189A1 MA 39189 A MA39189 A MA 39189A MA 39189 A MA39189 A MA 39189A MA 39189 A1 MA39189 A1 MA 39189A1
Authority
MA
Morocco
Prior art keywords
antibacterials
indazole
indole
derivatives
formula
Prior art date
Application number
MA39189A
Other languages
English (en)
French (fr)
Inventor
Christian Hubschwerlen
Jean-Philippe Surivet
Jean-Christophe Gauvin
Azely Mirre
Etienne Ochala
Jean-Luc Specklin
Gaëlle Chapoux
Original Assignee
Actelion Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Actelion Pharmaceuticals Ltd filed Critical Actelion Pharmaceuticals Ltd
Publication of MA39189A1 publication Critical patent/MA39189A1/fr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404Indoles, e.g. pindolol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/54Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
    • C07D231/56Benzopyrazoles; Hydrogenated benzopyrazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
MA39189A 2013-12-19 2014-12-18 Dérivés de 1h-indazole et de 1h-indole antibactériens MA39189A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP13198338 2013-12-19
PCT/EP2014/078384 WO2015091741A1 (en) 2013-12-19 2014-12-18 Antibacterial 1h-indazole and 1h-indole derivatives

Publications (1)

Publication Number Publication Date
MA39189A1 true MA39189A1 (fr) 2017-06-30

Family

ID=49880464

Family Applications (1)

Application Number Title Priority Date Filing Date
MA39189A MA39189A1 (fr) 2013-12-19 2014-12-18 Dérivés de 1h-indazole et de 1h-indole antibactériens

Country Status (22)

Country Link
US (1) US9624206B2 (cg-RX-API-DMAC7.html)
EP (1) EP3083567B1 (cg-RX-API-DMAC7.html)
JP (1) JP6407288B2 (cg-RX-API-DMAC7.html)
KR (1) KR20160098503A (cg-RX-API-DMAC7.html)
CN (1) CN105829288B (cg-RX-API-DMAC7.html)
AR (1) AR100032A1 (cg-RX-API-DMAC7.html)
AU (1) AU2014368619B2 (cg-RX-API-DMAC7.html)
BR (1) BR112016014115A8 (cg-RX-API-DMAC7.html)
CA (1) CA2933604A1 (cg-RX-API-DMAC7.html)
CL (1) CL2016001524A1 (cg-RX-API-DMAC7.html)
EA (1) EA030730B1 (cg-RX-API-DMAC7.html)
ES (1) ES2666130T3 (cg-RX-API-DMAC7.html)
IL (1) IL246201A0 (cg-RX-API-DMAC7.html)
MA (1) MA39189A1 (cg-RX-API-DMAC7.html)
MX (1) MX360983B (cg-RX-API-DMAC7.html)
PH (1) PH12016501102A1 (cg-RX-API-DMAC7.html)
PL (1) PL3083567T3 (cg-RX-API-DMAC7.html)
SG (1) SG11201605014YA (cg-RX-API-DMAC7.html)
TR (1) TR201807881T4 (cg-RX-API-DMAC7.html)
TW (1) TW201609641A (cg-RX-API-DMAC7.html)
WO (1) WO2015091741A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201604968B (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
WO2015173329A1 (en) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives
AU2015349005A1 (en) 2014-11-19 2017-07-06 Idorsia Pharmaceuticals Ltd Antibacterial benzothiazole derivatives
AR105646A1 (es) 2015-08-11 2017-10-25 Actelion Pharmaceuticals Ltd Agentes antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituida
EP3341378A1 (en) * 2015-08-28 2018-07-04 Idorsia Pharmaceuticals Ltd Antibacterial annulated pyrrolidin-2-one derivatives
AR105848A1 (es) * 2015-08-31 2017-11-15 Actelion Pharmaceuticals Ltd Derivados heterocíclicos antibacterianos
AR105889A1 (es) 2015-09-03 2017-11-22 Actelion Pharmaceuticals Ltd Compuestos antibacterianos 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona sustituidos
KR20190009324A (ko) * 2016-05-17 2019-01-28 이도르시아 파마슈티컬스 리미티드 6-(부타-1,3-디인-1-일)벤조[d]티아졸 유도체
WO2018216822A1 (en) 2017-05-25 2018-11-29 Taisho Pharmaceutical Co., Ltd. Novel imidazole derivatives
WO2019086452A1 (en) * 2017-10-31 2019-05-09 Idorsia Pharmaceuticals Ltd Antibacterial heteroaromatic compounds
CN113666860B (zh) * 2020-05-14 2024-03-15 鲁南制药集团股份有限公司 一种7-乙基色醇的制备方法
CN119014415B (zh) * 2024-08-19 2025-09-05 浙江大学 1-甲氧基吲哚在驱避和/或杀灭害虫中的应用

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI350285B (en) 2002-03-13 2011-10-11 Array Biopharma Inc N3 alkylated benzimidazole derivatives as mek inhibitors
DE102004017930A1 (de) 2004-04-14 2005-11-03 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue Alkin-Verbindungen mit MCH-antagonistischer Wirkung und diese Verbindungen enthaltende Arzneimittel
CN101389335A (zh) 2004-10-18 2009-03-18 安姆根有限公司 噻二唑化合物和使用方法
KR100973609B1 (ko) 2005-03-23 2010-08-03 에프. 호프만-라 로슈 아게 mGluR2 길항제로서 아세틸렌일-피라졸로-피리미딘유도체
CN101765585B (zh) 2007-06-12 2017-03-15 尔察祯有限公司 抗菌剂
US8372807B2 (en) 2009-05-20 2013-02-12 Ardea Biosciences, Inc. Methods of modulating uric acid levels
WO2011045703A2 (en) * 2009-10-13 2011-04-21 Pfizer Inc. C-linked hydroxamic acid derivatives useful as antibacterial agents
WO2011073845A1 (en) 2009-12-16 2011-06-23 Pfizer Inc. N-linked hydroxamic acid derivatives useful as antibacterial agents
GB2483736B (en) 2010-09-16 2012-08-29 Aragon Pharmaceuticals Inc Estrogen receptor modulators and uses thereof
TW201249786A (en) 2010-11-10 2012-12-16 Achaogen Inc Antibacterial agents
JP2014501274A (ja) 2011-01-03 2014-01-20 ハンミ ファーム. シーオー., エルティーディー. Gタンパク質共役受容体調節のための新規な二環式化合物
AP3336A (en) * 2011-03-07 2015-07-31 Pfizer Fluoro-pyridinone derivatives useful as antibacterial agents
US8748466B2 (en) 2011-04-08 2014-06-10 Pfizer Inc. Isoxazole derivatives useful as antibacterial agents
WO2012137099A1 (en) * 2011-04-08 2012-10-11 Pfizer Inc. Imidazole, pyrazole, and triazole derivatives useful as antibacterial agents
WO2013170030A1 (en) 2012-05-09 2013-11-14 Achaogen, Inc. Antibacterial agents
EP2847168A1 (en) 2012-05-10 2015-03-18 Achaogen, Inc. Antibacterial agents
AR097617A1 (es) 2013-09-13 2016-04-06 Actelion Pharmaceuticals Ltd Derivados antibacterianos del 2h-indazol
AR099612A1 (es) 2014-03-04 2016-08-03 Actelion Pharmaceuticals Ltd Derivados antibacterianos de 1,2-dihidro-3h-pirrolo[1,2-c]imidazol-3-ona
WO2015173329A1 (en) 2014-05-16 2015-11-19 Actelion Pharmaceuticals Ltd Antibacterial quinazoline-4(3h)-one derivatives

Also Published As

Publication number Publication date
BR112016014115A8 (pt) 2017-12-26
JP2017500336A (ja) 2017-01-05
AR100032A1 (es) 2016-09-07
CL2016001524A1 (es) 2017-01-27
ES2666130T3 (es) 2018-05-03
KR20160098503A (ko) 2016-08-18
EA030730B1 (ru) 2018-09-28
CN105829288A (zh) 2016-08-03
MX2016007991A (es) 2016-10-07
JP6407288B2 (ja) 2018-10-17
AU2014368619B2 (en) 2018-11-22
AU2014368619A1 (en) 2016-07-28
MX360983B (es) 2018-11-22
CA2933604A1 (en) 2015-06-25
CN105829288B (zh) 2019-01-15
EA201600475A1 (ru) 2016-11-30
PL3083567T3 (pl) 2018-08-31
BR112016014115A2 (cg-RX-API-DMAC7.html) 2017-08-08
EP3083567B1 (en) 2018-03-07
TW201609641A (zh) 2016-03-16
PH12016501102A1 (en) 2016-07-11
SG11201605014YA (en) 2016-07-28
ZA201604968B (en) 2018-11-28
TR201807881T4 (tr) 2018-06-21
US20170029411A1 (en) 2017-02-02
WO2015091741A1 (en) 2015-06-25
US9624206B2 (en) 2017-04-18
EP3083567A1 (en) 2016-10-26
IL246201A0 (en) 2016-08-02

Similar Documents

Publication Publication Date Title
MA39189A1 (fr) Dérivés de 1h-indazole et de 1h-indole antibactériens
MA35926B1 (fr) Pyrrolidine-2-carboxamides substitués
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
BR112015018738A2 (pt) compostos de tetra-hidropirrolotiazina
MA35089B1 (fr) Inhibiteurs de la production de leucotrienes de type benzodioxane
MA38645A1 (fr) Nouveaux inhibiteurs de cyp17/antiandrogènes
MA37142A3 (fr) Dérivés de dihydro-benzo-oxazine et de dihydro-pyrido-oxazine
MA34006B1 (fr) Derives de dihydrofurane utilises comme composes insecticides
MA38404A1 (fr) Nouveaux dérivés de pyridine
MA38540B1 (fr) Dérivés de naphtyridine utiles comme antagonistes de l'intégrine alpha-v-bêta-6
MA38583A1 (fr) Dérivés de dolastatine 10 et d'auristatines
MA37519B1 (fr) Composés et compositions pour inhiber l'activité d'abl1, abl2 et bcr-abl1
GT201500334A (es) Compuestos de 3,4- dihidroisoquinolin-2-(1h)-ilo
EP2964208A4 (en) TOPICAL USE OF ANTIMICROBIC FORMULATION
UY31065A1 (es) Heterociclos ciclicos
MX2016002241A (es) Alcoholes de alquinilo y metodos de uso.
MA38403A1 (fr) Nouveaux dérivés de pyrazole modulateurs specifiques de cb2
EA201491854A1 (ru) Асимметрический синтез соединений спирооксиндола, полезных в качестве терапевтических средств
BR112014028718A2 (pt) derivados de hidantoína como inibidores de kv3
MA35086B1 (fr) Compose de triazolopyridine
MA40302A1 (fr) Dérivés de carbazole
MX373603B (es) Activador de canales de kcnq2-5.
BR112015029348A2 (pt) inibidores da bace
BR112015026967A2 (pt) compostos fenoxietil di-hidro-1h-isoquinolina
MA39171A1 (fr) Dérivés d'hydroxy formamide et leur utilisation